Tianyang Mao
Auto-generated profile, based on publicly available information

Tianyang Mao

Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
CLCarolina Lucas
Carolina Lucas
PWPatrick Wong
Patrick Wong
JKJon Klein
Jon Klein
TCTiago B. R. Castro
Tiago B. R. Castro
JSJulio Silva
Julio Silva
AIAkiko Iwasaki
Akiko Iwasaki

26 August 2020 in Nature
Verified
Journal Article
Open access
PDF file
TTTakehiro Takahashi
Takehiro Takahashi
MEMallory K. Ellingson
Mallory K. Ellingson
PWPatrick Wong
Patrick Wong
BIBenjamin Israelow
Benjamin Israelow
CLCarolina Lucas
Carolina Lucas
AIAkiko Iwasaki
Akiko Iwasaki
There is increasing evidence that coronavirus disease 2019 (COVID-19) produces more severe symptoms and higher mortality among men than among women1,2,3,4,5. However, whether immune responses against severe acute respiratory syndrome coronavirus (SARS-CoV-2) differ between sexes, and whether such differences correlate with the sex difference in the disease course of COVID-19, is currently unknown. Here we examined sex differences in viral loads, SARS-CoV-2-specific antibody titres, plasma cytokines and blood-cell phenotyping in patients with moderate COVID-19 who had not received immunomodulatory medications. Male patients had higher plasma levels of innate immune cytokines such as IL-8 and IL-18 along with more robust induction of non-classical monocytes. By contrast, female patients had more robust T cell activation than male patients during SARS-CoV-2 infection. Notably, we found that a poor T cell response negatively correlated with patients’ age and was associated with worse disease outcome in male patients, but not in female patients. By contrast, higher levels of innate immune cytokines were associated with worse disease progression in female patients, but not in male patients. These findings provide a possible explanation for the observed sex biases in COVID-19, and provide an important basis for the development of a sex-based approach to the treatment and care of male and female patients with COVID-19.

19 May 2021 in Nature
Verified
Journal Article
Closed access
EWEric Y. Wang
Eric Y. Wang
TMTianyang Mao
Tianyang Mao
JKJon Klein
Jon Klein
YDYile Dai
Yile Dai
JHJohn D. Huck
John D. Huck
ARAaron M. Ring
Aaron M. Ring

24 September 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AWAnne L. Wyllie
Anne L. Wyllie
JFJohn Fournier
John Fournier
ACArnau Casanovas-Massana
Arnau Casanovas-Massana
MCMelissa Campbell
Melissa Campbell
MTMaria Tokuyama
Maria Tokuyama
AKAlbert I. Ko
Albert I. Ko
Rapid and accurate diagnostic tests are essential for controlling the ongoing Covid-19 pandemic. Although the current standard involves testing of nasopharyngeal swab specimens by quantitative reverse-transcriptase polymerase chain reaction (RT-qPCR) to detect SARS-CoV-2, saliva specimens may be an alternative diagnostic sample.1-4 Rigorous evaluation is needed to determine how saliva specimens compare with nasopharyngeal swab specimens with respect to sensitivity in detection of SARS-CoV-2 during the course of infection.

10 July 2020 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
CVChantal Vogels
Chantal Vogels
ABAnderson F. Brito
Anderson F. Brito
AWAnne L. Wyllie
Anne L. Wyllie
JFJoseph R. Fauver
Joseph R. Fauver
IOIsabel M. Ott
Isabel M. Ott
NGNathan D. Grubaugh
Nathan D. Grubaugh

25 September 2023 in Nature
Verified
Journal Article
Open access
PDF file
JKJon Klein
Jon Klein
JWJamie Wood
Jamie Wood
JJJillian R. Jaycox
Jillian R. Jaycox
RDRahul M. Dhodapkar
Rahul M. Dhodapkar
PLPeiwen Lu
Peiwen Lu
AIAkiko Iwasaki
Akiko Iwasaki
Post-acute infection syndromes may develop after acute viral disease1. Infection with SARS-CoV-2 can result in the development of a post-acute infection syndrome known as long COVID. Individuals with long COVID frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions2–4. However, the biological processes that are associated with the development and persistence of these symptoms are unclear. Here 275 individuals with or without long COVID were enrolled in a cross-sectional study that included multidimensional immune phenotyping and unbiased machine learning methods to identify biological features associated with long COVID. Marked differences were noted in circulating myeloid and lymphocyte populations relative to the matched controls, as well as evidence of exaggerated humoral responses directed against SARS-CoV-2 among participants with long COVID. Furthermore, higher antibody responses directed against non-SARS-CoV-2 viral pathogens were observed among individuals with long COVID, particularly Epstein–Barr virus. Levels of soluble immune mediators and hormones varied among groups, with cortisol levels being lower among participants with long COVID. Integration of immune phenotyping data into unbiased machine learning models identified the key features that are most strongly associated with long COVID status. Collectively, these findings may help to guide future studies into the pathobiology of long COVID and help with developing relevant biomarkers.